| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |